2,4,6-TRI-O-BENZYL-3-O-LEVULINOYL-ALPHA-D-GALACTOPYRANOSYL-TRICHLORACETIMIDATE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 3TVVioSAI5V |
|---|---|
| InChI | InChI=1S/C34H36Cl3NO8/c1-23(39)17-18-28(40)45-30-29(42-20-25-13-7-3-8-14-25)27(22-41-19-24-11-5-2-6-12-24)44-32(46-33(38)34(35,36)37)31(30)43-21-26-15-9-4-10-16-26/h2-16,27,29-32,38H,17-22H2,1H3/t27-,29+,30+,31-,32-/m1/s1 |
| InChIKey | ZWIVCRQDDPMXBB-YGMVDIOKSA-N |
| Mol Weight | 693.0 g/mol |
| Molecular Formula | C34H36Cl3NO8 |
| Exact Mass | 691.15065 g/mol |
| Enantiomer InChIKey | ZWIVCRQDDPMXBB-QIOBSBORSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
4-O-ACETYL-2,3,6-TRI-O-BENZYL-BETA-D-GLUCOPYRANOSYL-TRICHLOROACETIMIDATE
4-O-ACETYL-2,3,6-TRI-O-BENZYL-ALPHA-D-GLUCOPYRANOSYL-TRICHLOROACETIMIDATE
3-O-ACETYL-2,4,6-TRI-O-BENZYL-ALPHA-D-GALACTOPYRANOSYL-2,3,4,6-TETRA-O-BENZYL-ALPHA-D-MANNOPYRANOSIDE
3-O-ACETYL-2,4,6-TRI-O-BENZYL-BETA-D-GALACTOPYRANOSYL-2,3,4,6-TETRA-O-BENZYL-ALPHA-D-MANNOPYRANOSIDE
O-(2,3,4,6-Tetra-O-pivaloyl-b-d-glucopyranosyl)-trichloroacetimidate
4-O-METHYL-2,3,6-TRI-O-PIVALOYL-ALPHA-D-GALACTOPYRANOSYL-TRICHLOROACETIMIDATE
1,2-Di-O-(6-heptenoyl)-4,5,6-tri-O-benzyl-D-glycopyranose
2-(2',3',4',6'-Tetra-O-benzyl-b-D-glucopyranosyloxy)naphthalene
METHYL-4,6'-O-(1,3-XYLYLENE)-(2,3,4-TRI-O-BENZYL-BETA-D-GLUCOPYRANOSYL-(1'->6)-2,3-DI-O-BENZYL-ALPHA-D-GLUCOPYRANOSIDE
N-PENTENYL-3,6-DI-O-BENZYL-4-O-LEVULINYL-2-O-PIVALOYL-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Linear Synthesis of the Tumor-Associated Carbohydrate Antigens Globo-H, SSEA-3, and Gb3 | The Journal of Organic Chemistry | 2002 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.